Short communication: Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor in advanced brain tumor patients: Preliminary study

T. Crombet, N. Iznaga, R. Pérez, A. Lage, O. Torres, V. Rodríguez, A. Menéndez, A. Stevenson, M. Ramos, F. Torres, R. Figueredo, I. Veitía

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Fingerprint

Dive into the research topics of 'Short communication: Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor in advanced brain tumor patients: Preliminary study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Immunology and Microbiology